Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0231530 (
twitching
)
2,043
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Guanidinoethanesulfonic acid
(
GES
) is known to induce convulsive seizures when administered intracisternally to rabbits and cats. The effects of
GES
on behavior, electroencephalographic recording and brain monoamine levels were examined in mice. When
GES
(900 nmol) was intraventricularly injected into mice, focal clonic movements of the face, vibrissae and ears together with
twitching
of the limbs were observed 0.5-1 min after the injection. Hypersensitivity was observed up to 7 min after the injection, after which the mice behaved normally.
GES
also induced sporadic spike discharges on electrocorticogram. The levels of 5-hydroxytryptamine (5-HT) of the
GES
-injected mice were lower than those of the saline-injected mice in the hippocampus, diencephalon, pons-medulla oblongata and cerebellum 5 min after the injection. No changes in the norepinephrine or dopamine levels were found after the
GES
injection. The level of 5-hydroxyindoleacetic acid increased in the striatum and cerebellum 5 min after the
GES
injection. These results suggest that
GES
-induced convulsive activities enhance the serotonergic neuroactivity in order to suppress the convulsions.
...
PMID:Effect of guanidinoethanesulfonic acid on brain monoamines in the mouse. 172 53